Expression of factor IX in gene therapy vectors
Two mechanisms are provided for improving the expression of Factor IX in gene therapy vectors. The first is the use of a specific Factor IX polynucleotide coding sequence designed for optimal expression. The second is the use of transcriptional regulatory regions minimized in size so that they can be used to express Factor IX, as well as any other gene of interest, in a size-constrained environment such as in a self complementary gene therapy vector system.
1. A polynucleotide coding for human Factor IX comprising the sequence set forth in SEQ ID No. 1.
2. An expression cassette which expresses in a cell human Factor IX comprising the polynucleotide of claim 1 .
3. A gene therapy vector which expresses in a cell human Factor IX comprising the polynucleotide of claim 1 .
4. In a recombinant gene which expresses human Factor IX in a cell, an improvement comprising the use of the coding sequence for human Factor IX set forth in SEQ ID No. 1.
5. A recombinant gene comprising a transcriptional regulatory control region consisting of a polynucleotide consisting of SEQ ID No. 3, or an enhancer consisting of nucleotides 1-192 of SEQ ID No. 3, or a promoter consisting of nucleotides 193-447 of SEQ ID No. 3, wherein said transcription regulatory control region, said enhancer or said promoter regulates the expression of an operably linked coding sequence when introduced into a cell.
6. The recombinant gene of claim 5 , wherein said transcriptional regulatory control region is operably linked to a coding sequence for human Factor IX.
7. The recombinant gene of claim 6 , wherein said coding sequence is set forth in SEQ ID No. 1.
8. A gene therapy vector comprising a transcriptional regulatory control region having the sequence set forth in SEQ ID No. 3 operably linked to a polynucleotide coding for human Factor IX comprising the sequence set forth in SEQ ID No. 1.
9. An expression cassette comprising a transcriptional regulatory control region operably linked to a polynucleotide, wherein said transcriptional regulatory control region consists of SEQ ID No. 3.
10. A vector comprising the expression cassette of claim 9 .
11. An expression cassette comprising a recombinant gene having an enhancer region for enhancing the expression of an operably linked polynucleotide in liver tissue, wherein said enhancer region consists of nucleotides 1-192 of SEQ ID No. 3.
12. An expression cassette comprising a recombinant gene having a promoter region for promoting the expression of an operably linked polynucleotide in liver tissue, wherein said promoter region consists of nucleotides 193-447 of SEQ ID No. 3.